Interleukin-10 protects neonatal mice from lethal group B streptococcal infection

Infection and Immunity

Volumn 64, Issue 7, 1996, Pages 2850-2852

  Cusumano, Vitaliano ^a   Genovese, Francesco ^a   Mancuso, Giuseppe ^a   Carbone, Maria ^a   Fera, Maria Teresa ^a   Teti, Giuseppe ^a,b  

^a UNIVERSITY OF MESSINA   (Italy)

^b Istituto di Microbiologia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; NEUTRALIZING ANTIBODY; RECOMBINANT INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; IMMUNOMODULATION; IMMUNOPROPHYLAXIS; NEWBORN; NEWBORN INFECTION; NONHUMAN; PRIORITY JOURNAL; SEPSIS; STREPTOCOCCUS AGALACTIAE; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL;

EID: 0029885238     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.7.2850-2852.1996     Document Type: Article

References (22)

1. Baker, C. 1986. Group B strcptococcal infections in newborns. N. Engl. J. Med. 314:1702-1708.
2. Bean, R., A. Freiberg, S. Andrade, S. Menon, and A. Zlotnik. 1993, Interleukin-10 protects mice against staphylococcal enteroloxin B-induced lethal shock. Infect. Immun. 61:4937-4939.
3. Derkx, H. H. F., A. Marchant, M. Goldmann, R. P. C. M. Bijemer, and S. J. H. Van Deventer. 1995. High levels of interleukin-10 during the initial phase of fulminant meningococcal septic shock. J. Infect. Dis. 171:229-232.
4. de Waal Malefyt, R., J. Abrams, B. Bennett, C. G. Figdor, and J. E. de Vries. 1991. Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: an autorcgulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1209-1229.
5. Espevik, T., and J. Nissen-Meyer. 1986. A highly sensitive cell line WEHI 164 clone 13 for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods 95:99.
6. Fiorentino, D. F., M. W. Bond, and T. R. Mosmann. 1989. Two types of mouse T helper cell: IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170:2081-2086.
7. Florquin, S., Z. Amraoui, D. Ahramowicz, and M. Goldman. 1994. Systemic release and protective role of IL-10 in staphylococcal enterotoxin B-induced shock in mice, J. Immunol. 153:2318-2323.
8. Gérard, C., C. Bruyns, A. Marchant, D. Abramowicz, P. Vandenabeele, A. Delvaux, W. Fiers, M. Goldman, and T. Velu. 1993. Interleukin-10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177:547-550.
9. Ghalib, H. W., M. R. Piuvezam, A. W. Skeiky, M. Siddig, A. M. Hashim, A. M. EI-Hassan, D. M. Russo, and S. G. Reed. 1993. Interleukin-10 production correlates with pathology in human Leishmania donovani infections. J. Clin. Invest. 92:324-330.
10. Greenberger, M. J., R. M. Stricter, S. L. Kunkel, J. M. Danforth, R. E. Goodmann, and T. J. Standiford. 1995. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumoniae. J. Immunol. 155:722-729.
11. Howard, M., T. Muchamuel, S. Andrade, and S. Menon. 1993. Interleukin-10 protects mice from lethal endotoxemia. J. Exp. Med. 177:1205-1208.
12. Mancuso, G., F. Tomasello, M. Migliardo, D. Delfino, J. A. Cochran, J. A. Cook, and G. Teti. 1994. Beneficial effects of interlcukin-6 in neonatal mouse models of group B streptococcal disease. Infect. Immun. 62:4997-5002.
13. Marques, M. B., D. L. Kasper, M. K. Pangburn, and M. R. Wessels. 1992. Prevention of C3 deposition by capsular polysaccharidc is a virulence mechanism of type III group B streptococci. Infect. Immun. 60:3986-3993.
14. Moore, K. W., A. O'Garra, R. de Waal Malefyt, P. Vieira, and T. R. Mosmann. 1993. Interleukin-10. Annu. Rev. Immunol. 11:165-190.
15. Mosmann, T. R., J. H. Schumaker, D. F. Fiorentino, J. Leverah, K. W. Moore, and M. W. Bond. 1990. Isolation of monoclonal antibodies specific for IL-4. IL-5. IL-6. and a new Th2-specific cytokine (IL10), cytokine synthesis inhibitory factor, by using a solid phase radioimmunoadsorbent assay. J. Immunol. 145:2938-2945.
16. O'Garra, A., R. Chang, R. Hastings, N. Go, G. Haughton, and M. Howard. 1992. Lyl B (B-1) cells are the main source of B-cell derived IL-10. Eur. J. Immunol. 22:711-717.
17. O'Garra, A., G. Stapleton, V. Dhar. M. Pearce, J. Schumacher, H. Hugo, D. Barbis, A. Stall, J. Cupp, K. Moore, P. Vieira, T. Mosmann, A. Whitmore, L. Arnold, G. Haughton, and M. Howard. 1990. Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10. Int. Immunol. 2:821-828.
18. Reed, S. G., C. E. Brownell, D. M. Russo, J. S. Silva. K. H. Grabstein, and P. J. Morrissey. 1994. IL-10 mediates susceptibility to Trypanosoma crutzi infection. J. Immunol. 153:3135-3141.
19. Smith, S. R., C. Terminelli, L. Kenworthy-Bott, A. Calzetta, and J. Uonkin. 1994. The cooperative effects of TNF-α and IFN-γ are determining factors in the ability of IL-10 to protect mice from lethal endotoxemia. J. Leukocyte Biol. 55:711-715.
20. Teli, G., G. Mancuso, and F. Tomasello. 1993. Cytokine appearance and effects of anti-tumor necrosis factor alpha antibodies in a neonatal rat model of group B streptococcal infection. Infect. Immun. 61:227-235.
21. Vieira, P., R. de Waal-Malefyt, M. W. Dang, K. E. Johnson, R. Kastelein, D. F. Florentine, J. E. de Vries, M. G. Roncarolo, T. R. Mosmann, and K. W. Moore. 1991. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI. Proc. Natl. Acad. Sci. USA 88:1172-1180.
22. Ziegler-Heitbrock, H. W. L. 1995. Molecular mechanism in tolerance to lipopolysaccharide. J. Inflamrn. 45:13-26.